Mycophenolate mofetil monotherapy in liver transplantation

Lancet

Volumn 357, Issue 9256, 2001, Pages 609-610

  Stewart, S F ^a   Hudson, M ^a   Talbot, D ^a   Manas, D ^a   Day, C P ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOSE RESPONSE; DRUG WITHDRAWAL; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035941756     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04065-4     Document Type: Article

References (3)

1. Chronic renal failure following liver transplantation
2. Four-year follow-up of mycophenolate mofetil for graft rescue in liver allograft recipients
3. Mycophenolate mofetil monotherapy in stable liver transplant patients with cyclosporin induced renal impairment